Mutagenetix > Incidental Mutation

Incidental Mutation 'R0755:Fdxacb1'

70437

Institutional Source

Beutler Lab

Gene Symbol

Fdxacb1

Ensembl Gene

ENSMUSG00000037845

Gene Name

ferredoxin-fold anticodon binding domain containing 1

Synonyms

D630004A14Rik

MMRRC Submission

038935-MU

Accession Numbers

Essential gene?

Non essential (E-score: 0.000) question?

Stock #

R0755 (G1)

Quality Score

225

Status

Not validated

Chromosome

Chromosomal Location

50679538-50683981 bp(+) (GRCm39)

Type of Mutation

missense

DNA Base Change (assembly)

T to A at 50683025 bp (GRCm39)

Zygosity

Heterozygous

Amino Acid Change

Aspartic acid to Glutamic Acid at position 329 (D329E)

Ref Sequence

ENSEMBL: ENSMUSP00000037082 (fasta)

Gene Model

predicted gene model for transcript(s): [ENSMUST00000034561] [ENSMUST00000042391] [ENSMUST00000042468] [ENSMUST00000159576] [ENSMUST00000162073] [ENSMUST00000176335] [ENSMUST00000176238] [ENSMUST00000177546] [ENSMUST00000176145] [ENSMUST00000177384]

AlphaFold

Q3UY23

Predicted Effect

probably benign
Transcript: ENSMUST00000034561

SMART Domains

Protein: ENSMUSP00000034561
Gene: ENSMUSG00000032059

Domain	Start	End	E-Value	Type
Pfam:Glyco_transf_22	60	482	3.5e-127	PFAM
low complexity region	598	611	N/A	INTRINSIC

Predicted Effect

possibly damaging
Transcript: ENSMUST00000042391
AA Change: D329E

PolyPhen 2 Score 0.871 (Sensitivity: 0.83; Specificity: 0.93)

SMART Domains

Protein: ENSMUSP00000037082
Gene: ENSMUSG00000037845
AA Change: D329E

Domain	Start	End	E-Value	Type
Pfam:DUF2431	7	176	1.4e-44	PFAM
low complexity region	258	269	N/A	INTRINSIC
SCOP:d1jjca_	487	516	6e-4	SMART
FDX-ACB	528	622	5.88e-17	SMART

Predicted Effect

probably benign
Transcript: ENSMUST00000042468

SMART Domains

Protein: ENSMUSP00000041803
Gene: ENSMUSG00000037971

Domain	Start	End	E-Value	Type
Pfam:DUF1143	1	149	7.7e-107	PFAM

Predicted Effect

probably benign
Transcript: ENSMUST00000159576

SMART Domains

Protein: ENSMUSP00000123711
Gene: ENSMUSG00000032059

Domain	Start	End	E-Value	Type
Pfam:Glyco_transf_22	60	228	1e-43	PFAM

Predicted Effect

probably benign
Transcript: ENSMUST00000162073

SMART Domains

Protein: ENSMUSP00000125425
Gene: ENSMUSG00000032059

Domain	Start	End	E-Value	Type
Pfam:Glyco_transf_22	60	167	7.5e-31	PFAM

Predicted Effect

noncoding transcript
Transcript: ENSMUST00000162363

Predicted Effect

noncoding transcript
Transcript: ENSMUST00000162442

Predicted Effect

possibly damaging
Transcript: ENSMUST00000176335
AA Change: D127E

PolyPhen 2 Score 0.845 (Sensitivity: 0.83; Specificity: 0.93)

SMART Domains

Protein: ENSMUSP00000135658
Gene: ENSMUSG00000037845
AA Change: D127E

Domain	Start	End	E-Value	Type
low complexity region	56	67	N/A	INTRINSIC
SCOP:d1jjca_	285	314	3e-4	SMART
FDX-ACB	326	420	5.88e-17	SMART

Predicted Effect

noncoding transcript
Transcript: ENSMUST00000176619

Predicted Effect

noncoding transcript
Transcript: ENSMUST00000176894

Predicted Effect

noncoding transcript
Transcript: ENSMUST00000177022

Predicted Effect

noncoding transcript
Transcript: ENSMUST00000177142

Predicted Effect

noncoding transcript
Transcript: ENSMUST00000176160

Predicted Effect

probably benign
Transcript: ENSMUST00000176238

SMART Domains

Protein: ENSMUSP00000135679
Gene: ENSMUSG00000037971

Domain	Start	End	E-Value	Type
Pfam:DUF1143	1	70	4.2e-47	PFAM
Pfam:DUF1143	68	126	5.3e-38	PFAM

Predicted Effect

probably benign
Transcript: ENSMUST00000177546

SMART Domains

Protein: ENSMUSP00000134870
Gene: ENSMUSG00000037971

Domain	Start	End	E-Value	Type
Pfam:DUF1143	13	72	3.3e-39	PFAM

Predicted Effect

probably benign
Transcript: ENSMUST00000176145

SMART Domains

Protein: ENSMUSP00000135796
Gene: ENSMUSG00000037845

Domain	Start	End	E-Value	Type
Pfam:DUF2431	7	115	4.2e-33	PFAM

Predicted Effect

probably benign
Transcript: ENSMUST00000177384

Coding Region Coverage

1x: 99.2%
3x: 98.6%
10x: 97.1%
20x: 93.8%

Validation Efficiency

MGI Phenotype

FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a protein which contains a ferredoxin-fold anticodon-binding domain which is contained in a subset of phenylalanyl tRNA synthetases. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]

Allele List at MGI

Other mutations in this stock

Total: 94 list
Gene	Ref	Var	Chr/Loc	Mutation	Predicted Effect	Zygosity
A730061H03Rik	A	T	14: 55,797,638 (GRCm39)		probably benign	Het
Acin1	A	G	14: 54,889,292 (GRCm39)	M1T	probably null	Het
Akp3	G	A	1: 87,055,593 (GRCm39)	G547R	unknown	Het
Aldh1a1	A	G	19: 20,595,358 (GRCm39)	M96V	probably benign	Het
Ankfn1	T	A	11: 89,282,913 (GRCm39)	M245L	probably benign	Het
Arhgap19	T	C	19: 41,769,614 (GRCm39)	K54E	probably damaging	Het
Atp1a2	T	C	1: 172,116,948 (GRCm39)	Q223R	probably benign	Het
Atp8a2	C	T	14: 60,247,330 (GRCm39)	V557I	possibly damaging	Het
AU041133	A	T	10: 81,986,724 (GRCm39)	K126*	probably null	Het
Axin1	T	A	17: 26,401,480 (GRCm39)	Y351N	possibly damaging	Het
Baiap2l1	T	C	5: 144,221,367 (GRCm39)	K176E	probably damaging	Het
Baz2a	C	T	10: 127,955,560 (GRCm39)	T848I	possibly damaging	Het
Bbs2	A	C	8: 94,808,708 (GRCm39)	V333G	probably benign	Het
BC051019	G	A	7: 109,315,302 (GRCm39)	Q318*	probably null	Het
Bltp1	T	C	3: 37,000,513 (GRCm39)	S1231P	probably damaging	Het
Cdc37	C	T	9: 21,051,160 (GRCm39)	D362N	probably damaging	Het
Cep170	A	T	1: 176,583,319 (GRCm39)	V1020E	probably damaging	Het
Chrm4	T	C	2: 91,758,747 (GRCm39)	V385A	probably benign	Het
Cntrl	G	A	2: 35,035,151 (GRCm39)	S373N	probably damaging	Het
Col23a1	G	A	11: 51,467,706 (GRCm39)	G19D	probably damaging	Het
Cyb5r4	G	T	9: 86,911,625 (GRCm39)	A100S	probably damaging	Het
Dctn1	C	T	6: 83,166,059 (GRCm39)	P115S	probably damaging	Het
Dhrs2	C	T	14: 55,472,247 (GRCm39)	T46M	probably damaging	Het
Disp2	T	C	2: 118,620,243 (GRCm39)	F325S	probably benign	Het
Dnah11	T	G	12: 117,918,564 (GRCm39)	T3456P	possibly damaging	Het
Dnah11	C	A	12: 118,162,360 (GRCm39)	V70F	probably benign	Het
Duoxa1	T	A	2: 122,135,161 (GRCm39)	T195S	probably benign	Het
Dync2i1	T	C	12: 116,175,412 (GRCm39)	I922V	probably benign	Het
Eif2ak1	T	A	5: 143,821,742 (GRCm39)	F353I	possibly damaging	Het
Esam	A	G	9: 37,447,998 (GRCm39)	T211A	probably damaging	Het
Faf1	A	G	4: 109,819,036 (GRCm39)	N636S	probably benign	Het
Fbxo25	A	G	8: 13,985,219 (GRCm39)	Y305C	probably benign	Het
Fchsd1	C	T	18: 38,101,803 (GRCm39)		probably null	Het
Gvin2	A	T	7: 105,545,892 (GRCm39)	F2387I	possibly damaging	Het
Hbq1b	A	T	11: 32,237,104 (GRCm39)		probably null	Het
Hmcn2	T	A	2: 31,343,172 (GRCm39)	V4566E	probably damaging	Het
Igkv6-29	G	A	6: 70,116,053 (GRCm39)	T5I	probably benign	Het
Itfg1	A	T	8: 86,452,834 (GRCm39)	D511E	possibly damaging	Het
Jmjd1c	C	T	10: 66,932,378 (GRCm39)		probably benign	Het
Kat6b	T	A	14: 21,687,661 (GRCm39)	M570K	probably damaging	Het
Kdm4d	T	A	9: 14,375,591 (GRCm39)	K89M	probably damaging	Het
Krt19	A	T	11: 100,032,965 (GRCm39)	D194E	possibly damaging	Het
Lamc1	A	T	1: 153,123,196 (GRCm39)	Y665N	possibly damaging	Het
Lct	A	T	1: 128,221,872 (GRCm39)	S1556T	possibly damaging	Het
Macf1	A	G	4: 123,263,719 (GRCm39)	L4924P	probably damaging	Het
Mef2c	G	A	13: 83,804,472 (GRCm39)		probably null	Het
Mff	G	A	1: 82,728,326 (GRCm39)		probably null	Het
Mycbp2	A	T	14: 103,412,230 (GRCm39)	L2581Q	probably damaging	Het
Mylk	G	C	16: 34,699,845 (GRCm39)	E403Q	possibly damaging	Het
Nos3	T	A	5: 24,572,295 (GRCm39)	L123M	probably damaging	Het
Ntn5	C	T	7: 45,335,952 (GRCm39)	P128S	probably benign	Het
Nudt9	T	C	5: 104,212,920 (GRCm39)	V331A	probably damaging	Het
Or2y3	A	T	17: 38,393,085 (GRCm39)	Y261*	probably null	Het
Or7g34	T	C	9: 19,478,415 (GRCm39)	I88M	possibly damaging	Het
Pcdh7	A	T	5: 57,877,664 (GRCm39)	K406N	possibly damaging	Het
Pkdrej	T	A	15: 85,700,336 (GRCm39)	I1867L	probably benign	Het
Plppr4	C	T	3: 117,116,319 (GRCm39)	G455R	possibly damaging	Het
Pramel11	A	G	4: 143,624,299 (GRCm39)	V66A	probably damaging	Het
Prkag2	G	C	5: 25,152,629 (GRCm39)	S158R	probably benign	Het
Ptprq	T	G	10: 107,418,400 (GRCm39)	T1659P	probably benign	Het
Rasl12	A	G	9: 65,318,241 (GRCm39)	K202E	probably benign	Het
Rb1	A	C	14: 73,434,653 (GRCm39)	*922G	probably null	Het
Rsf1	C	T	7: 97,229,174 (GRCm39)	P22S	probably damaging	Het
Scn1a	T	G	2: 66,151,379 (GRCm39)	T797P	probably damaging	Het
Sgsm2	A	G	11: 74,756,323 (GRCm39)	V342A	probably damaging	Het
Slc22a7	T	G	17: 46,749,113 (GRCm39)	H68P	possibly damaging	Het
Slc4a2	G	A	5: 24,640,575 (GRCm39)	A652T	probably benign	Het
Slc5a1	T	A	5: 33,290,733 (GRCm39)	L106M	probably benign	Het
Slco1c1	C	T	6: 141,477,258 (GRCm39)	P19S	probably damaging	Het
Snx1	A	G	9: 66,005,738 (GRCm39)	F127S	probably damaging	Het
Snx31	A	T	15: 36,534,576 (GRCm39)	I199N	probably damaging	Het
Snx33	T	C	9: 56,832,741 (GRCm39)	I443V	possibly damaging	Het
Sptbn1	A	G	11: 30,089,016 (GRCm39)	F749L	probably damaging	Het
Stoml3	T	A	3: 53,405,559 (GRCm39)	Y53*	probably null	Het
Stxbp2	A	G	8: 3,692,019 (GRCm39)	T554A	probably benign	Het
Tal1	T	C	4: 114,925,573 (GRCm39)	I214T	probably damaging	Het
Tas2r140	T	A	6: 40,468,344 (GRCm39)	I58N	probably damaging	Het
Thap1	A	G	8: 26,648,501 (GRCm39)	Y8C	probably damaging	Het
Thsd7a	A	T	6: 12,555,368 (GRCm39)	L172Q	probably damaging	Het
Ube3c	T	A	5: 29,842,740 (GRCm39)	D735E	probably damaging	Het
Unc80	G	A	1: 66,544,082 (GRCm39)	D402N	probably damaging	Het
Upf1	G	T	8: 70,786,779 (GRCm39)	R902S	probably benign	Het
Urb1	A	G	16: 90,570,982 (GRCm39)	Y1276H	probably damaging	Het
Urb1	A	T	16: 90,576,026 (GRCm39)	F843L	probably benign	Het
Vmn1r198	C	T	13: 22,539,402 (GRCm39)	T296I	probably benign	Het
Vmn1r33	A	T	6: 66,588,892 (GRCm39)	S221T	probably damaging	Het
Vmn2r103	A	G	17: 19,993,830 (GRCm39)	D69G	probably benign	Het
Vmn2r14	T	G	5: 109,364,226 (GRCm39)	L563F	possibly damaging	Het
Vmn2r60	G	A	7: 41,844,869 (GRCm39)	G744D	probably damaging	Het
Vstm4	T	C	14: 32,614,601 (GRCm39)	V181A	probably damaging	Het
Wdr72	G	A	9: 74,052,376 (GRCm39)	V136I	probably benign	Het
Zfp236	T	A	18: 82,638,457 (GRCm39)	N1388Y	probably damaging	Het
Zfp53	T	A	17: 21,728,839 (GRCm39)	F291I	probably damaging	Het
Zfp944	A	T	17: 22,558,889 (GRCm39)	H119Q	possibly damaging	Het

Other mutations in Fdxacb1

Allele	Source	Chr	Coord	Type	Predicted Effect	PPH Score
IGL02403:Fdxacb1	APN	9	50,682,863 (GRCm39)	missense	possibly damaging	0.75
IGL02828:Fdxacb1	APN	9	50,682,864 (GRCm39)	missense	possibly damaging	0.75
IGL02799:Fdxacb1	UTSW	9	50,683,896 (GRCm39)	missense	probably benign	0.01
R1283:Fdxacb1	UTSW	9	50,679,994 (GRCm39)	missense	possibly damaging	0.79
R1395:Fdxacb1	UTSW	9	50,683,796 (GRCm39)	frame shift	probably null
R1991:Fdxacb1	UTSW	9	50,682,946 (GRCm39)	missense	probably benign	0.00
R2103:Fdxacb1	UTSW	9	50,682,946 (GRCm39)	missense	probably benign	0.00
R2273:Fdxacb1	UTSW	9	50,683,321 (GRCm39)	missense	probably benign	0.01
R2913:Fdxacb1	UTSW	9	50,679,699 (GRCm39)	missense	probably benign	0.05
R2914:Fdxacb1	UTSW	9	50,679,699 (GRCm39)	missense	probably benign	0.05
R4289:Fdxacb1	UTSW	9	50,683,879 (GRCm39)	missense	probably damaging	0.99
R4492:Fdxacb1	UTSW	9	50,681,547 (GRCm39)	missense	probably damaging	0.99
R4668:Fdxacb1	UTSW	9	50,681,560 (GRCm39)	missense	possibly damaging	0.74
R4742:Fdxacb1	UTSW	9	50,679,968 (GRCm39)	unclassified	probably benign
R4789:Fdxacb1	UTSW	9	50,681,418 (GRCm39)	missense	possibly damaging	0.84
R4935:Fdxacb1	UTSW	9	50,683,243 (GRCm39)	missense	probably benign	0.00
R5190:Fdxacb1	UTSW	9	50,683,387 (GRCm39)	missense	possibly damaging	0.78
R5652:Fdxacb1	UTSW	9	50,679,705 (GRCm39)	missense	probably damaging	1.00
R6130:Fdxacb1	UTSW	9	50,683,902 (GRCm39)	nonsense	probably null
R7483:Fdxacb1	UTSW	9	50,681,451 (GRCm39)	missense	possibly damaging	0.89
R7487:Fdxacb1	UTSW	9	50,681,519 (GRCm39)	missense	possibly damaging	0.88
R7571:Fdxacb1	UTSW	9	50,683,093 (GRCm39)	missense	probably damaging	0.98
R8069:Fdxacb1	UTSW	9	50,680,135 (GRCm39)	missense	probably damaging	1.00
R8201:Fdxacb1	UTSW	9	50,681,455 (GRCm39)	unclassified	probably benign
R8907:Fdxacb1	UTSW	9	50,681,451 (GRCm39)	missense	probably damaging	0.97
R9331:Fdxacb1	UTSW	9	50,681,511 (GRCm39)	missense	probably damaging	1.00

Predicted Primers

PCR Primer
(F):5'- ACTCATTGCCGAATTGGGCAAAAC -3'
(R):5'- AGATGTGGCACTTCCGAAAGACAG -3'

Sequencing Primer
(F):5'- TTAAAAAGGCTGAAGTGTCCCCTC -3'
(R):5'- TTCCGAAAGACAGGTCCACTG -3'

Posted On

2013-09-30